3Torre LA, Bray F, Siegel RL, et al. Global cancer statis- tics,2012[ J]. CA Cancer J Clin,2015,65(2) :87-108.
4Siegel RL, Miller KD, Jemal A, et al. Cancer statistics, 2015 [ J ]. CA Cancer J Clin, 2015,65 ( 1 ) : 5-29.
5Lee NK. Adjuvant treatment of advanced-stage endometrial cancer [ J ]. Clin Obstet Gyneco1,2011,54 (2) : 256-265.
6Zhuang T,Zhu J, Li Z,et al. p21-activated kinase group II small compound inhibitor GNE-2861 perturbs estrogen re- ceptor alpha signaling and restores tamoxifen-sensitivity in breast cancer cells [ J ]. Oncotarget, 2015 [ Epub ahead of print].
7Wang C, Li Y, Zhang H, et al. Oncogenic PAK4 regulates Smad2/3 axis involving gastric tumorigenesis [ J ]. Onco- gene ,2014,33 (26) :3473-3484.
8Siu MK,Chan HY, Kong DS, et al. p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients [ J ]. Proc Natl Acad Sci U S A,2010,107(43) : 18622-18627.
9Callow MG. Requirement for PAK4 in the Anchorage-inde- pendent Growth of Human Cancer Cell Lines [ J ]. J Biol Chem,2001,277( 1 ) :550-558.
10Park MH,Lee HS, Lee CS,et al. p21-Activated kinase 4 promotes prostate cancer progression through CREB [ J ]. Oncoe, ne 2013 32(19) ,2475-2482.
